Theodore Pincus to Clinical Protocols
This is a "connection" page, showing publications Theodore Pincus has written about Clinical Protocols.
Connection Strength
0.449
-
Why are only 50% of courses of anti-tumor necrosis factor agents continued for only 2 years in some settings? Need for longterm observations in standard care to complement clinical trials. J Rheumatol. 2006 Dec; 33(12):2372-5.
Score: 0.288
-
Evidence that the strategy is more important than the agent to treat rheumatoid arthritis. Data from clinical trials of combinations of non-biologic DMARDs, with protocol-driven intensification of therapy for tight control or treat-to-target. Bull Hosp Jt Dis (2013). 2013; 71 Suppl 1:S33-40.
Score: 0.110
-
Limitations of randomized clinical trials in chronic diseases: explanations and recommendations. Adv Mind Body Med. 2002; 18(2):14-21.
Score: 0.051